EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection

Sarah Razzaq iD, Francisco Olmo iD, Suresh B Lakshminarayana iD, Chen Ying-Bo, Shiromani Jayawardhana, Srinivasa P S Rao iD, John M Kelly iD, Francisco A F iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00135-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Sarah Razzaq und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Trypanocidal Agents. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiomyopathy is the most common pathology associated with Trypanosoma cruzi infection. Reports that statins have both cardioprotective and trypanocidal activity have generated interest in their potential as a therapeutic treatment. Using a highly sensitive bioluminescent mouse model, we show that a 5-day treatment with statins has no significant impact on parasite load. The free systemic concentrations fail to reach the level required for potency. Hence, clinical trials to investigate the trypanocidal activity of statins lack experimental justification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziChagas DiseaseHydroxymethylglutaryl-CoA Reductase InhibitorsTrypanocidal AgentsAnimalsMiceParasite LoadDisease Models, AnimalFemale

Stichwörter der Autor:innen

Chagas cardiomyopathyChagas diseaseTrypanosoma cruzibenznidazolefluvastatinpharmacokineticspravastatinsimvastatinstatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsTrypanocidal Agents

Autor:innen und Institutionen

  • Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Department of Parasitology, Faculty of Sciences, University of Granada, Granada, Andalusia, Spain.
  • Global Health, Biomedical Research, Novartis, Emeryville, California, USA.

ORCID-Profile: Sarah Razzaq, Francisco Olmo, Suresh B Lakshminarayana, Srinivasa P S Rao, John M Kelly, Francisco A F

Förderung

  • Medical Research Council UK

Zitieren

APA

Razzaq, S., Olmo, F., Lakshminarayana, S. B., Ying-Bo, C., Jayawardhana, S., Rao, S. P. S., Kelly, J. M., & A F, F. (2025). Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00135-25

Vancouver

Razzaq S, Olmo F, Lakshminarayana SB, Ying-Bo C, Jayawardhana S, Rao SPS, et al. Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00135-25

BibTeX
@article{Razzaq2025,
  author = {Razzaq, Sarah and Olmo, Francisco and Lakshminarayana, Suresh B and Ying-Bo, Chen and Jayawardhana, Shiromani and Rao, Srinivasa P S and Kelly, John M and A F, Francisco},
  title = {Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00135-25}
}
Kostenlos starten →